Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Aims: Obesity is a significant problem for patients taking atypical antipsychotics. There were two aims of our study. The first aim was to compare the prevalence of overweight and obesity between children and adolescents with autism spectrum disorder (ASD) treated with risperidone with the general p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Vanwong, Natchaya, Ngamsamut, Nattawat, Nuntamool, Nopphadol, Hongkaew, Yaowaluck, Sukprasong, Rattanaporn, Puangpetch, Apichaya, Limsila, Penkhae, Sukasem, Chonlaphat
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677569/
https://ncbi.nlm.nih.gov/pubmed/33240086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.565074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller